Fluticasone propionate adverse effects
Pro Research Analysisby 
Searched over 200M research papers
Common Adverse Effects of Fluticasone Propionate
Fluticasone propionate, whether used as a nasal spray, inhaler, or topical cream, is generally well tolerated. The most frequently reported adverse effects are mild and localized. For intranasal use, the most common side effects include nasal dryness, burning, epistaxis (nosebleeds), and headache. These effects occur at rates similar to those seen with placebo, indicating a favorable safety profile for most users 12. When used as an inhaled corticosteroid for asthma, adverse events are mainly localized to the oropharynx and larynx, such as throat irritation or hoarseness 58.
Systemic Adverse Effects and Safety Concerns
Fluticasone propionate is designed to have low systemic absorption, which reduces the risk of systemic corticosteroid side effects. Studies show that even at higher doses, intranasal and inhaled fluticasone propionate do not significantly suppress adrenal function or cause changes in bone mineral density, bone turnover, or eye health (such as cataracts or glaucoma) over long-term use 28. In children, topical fluticasone propionate cream used for up to four weeks did not significantly affect cortisol levels or cause notable skin side effects, supporting its safety in pediatric populations .
Comparison with Other Corticosteroids
When compared to other inhaled corticosteroids like beclomethasone dipropionate and budesonide, fluticasone propionate has a similar adverse effect profile, especially when used at equivalent or lower doses 167. Most side effects remain mild and localized, with no significant increase in systemic adverse events.
Adverse Effects in Chronic Obstructive Pulmonary Disease (COPD)
In patients with COPD, fluticasone propionate (alone or in combination with salmeterol) is associated with a higher risk of pneumonia compared to placebo or salmeterol alone. The incidence of pneumonia was reported to be 19.6% in combination therapy and 18.3% with fluticasone alone, compared to 12.3% with placebo 910. Other adverse events were similar across treatment groups, and no significant differences were found in ocular or bone side effects .
Adverse Effects in Children
In studies involving children with asthma or atopic dermatitis, fluticasone propionate did not increase the risk of adverse reactions such as nausea, vomiting, rash, or dizziness compared to other treatments or placebo. Its safety profile in pediatric use is considered favorable, with no significant increase in systemic or cutaneous side effects 347.
Conclusion
Fluticasone propionate is generally safe and well tolerated, with most adverse effects being mild and localized, such as nasal dryness, throat irritation, or nosebleeds. Systemic side effects are rare due to its low absorption, and long-term use does not significantly impact adrenal function, bone health, or eye health. However, in COPD patients, there is an increased risk of pneumonia that should be considered. Overall, fluticasone propionate offers a favorable safety profile for both adults and children when used as directed 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic